Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Read the full text
Published in the European Heart Journal in January 2016; ehv709DOI: 10.1093/eurheartj/ehv709
Authors: Victor Aboyans, Marco De Carlo, Serge Kownator, Lucia Mazzolai, Nicolas Meneveau, Jean-Baptiste Ricco, Charalambos Vlachopoulos, Marianne Brodmann on behalf of the ESC Working Group on Peripheral Circulation
A position paper from the ESC Working group on peripheral circulation
Published in the Atherosclerosis Journal in August 2015; 241(2):507-32; Epub 2015 May 16DOI: 10.1016/j.atherosclerosis.2015.05.007
Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society
Authors: Charalambos Vlachopoulos (Chairperson), Panagiotis Xaplanteris, Victor Aboyans, Marianne Brodmann, Renata Cífková, Francesco Cosentino, Marco De Carlo, Augusto Gallino, Ulf Landmesser, Stéphane Laurent, John Lekakis, Dimitri P. Mikhailidis, Katerina K. Naka, Athanasios D. Protogerou, Damiano Rizzoni, Arno Schmidt-Trucksäss, Luc Van Bortel, Thomas Weber, Akira Yamashina, Reuven Zimlichman
Published in the European Heart Journal in Mar 2015 ;36(10):591-7; Epub 2015 January 3DOI: 10.1093/eurheartj/ehu515
Authors: Victor Aboyans, Marianne Brodmann, Marco De Carlo, Denis Clement, Lucia Mazzolai, Lucas van Bortel, Marc R.H. van Sambeek, Charalambos Vlachopoulos
Abstract: In 2014, the debate on the indication of revascularization in case of asymptomatic carotid disease continued, while another one regarding the use of surgery vs. stenting addressed some new issues regarding the long-term cardiac risk of these patients. Renal arteries interventions trials were disappointing, as neither renal denervation nor renal artery stenting was found associated with better blood pressure management or outcome. In contrast, in lower-extremities artery disease, the endovascular techniques represent in 2014 major alternatives to surgery, even in distal arteries, with new insights regarding the interest of drug-eluting balloons. Regarding the aorta, the ESC published its first guidelines document on the entire vessel, emphasizing on the role of every cardiologist for screening abdominal aorta aneurysm during echocardiography. Among vascular wall biomarkers, the aorta stiffness is of increasing interest with new data and meta-analysis confirming its ability to stratify risk, whereas carotid intima-media thickness showed poor performances in terms of reclassifying patients into risk categories beyond risk scores. Regarding the veins, new data suggest the interest of D-dimers and residual venous thrombosis to help the decision of anti-coagulation prolongation or discontinuation after the initial period of treatment for deep vein thrombosis.
Published in the European Heart Journal in May 2014; 35(17):1112-9; Epub 2014 March 4DOI: 10.1093/eurheartj/ehu071
Authors: Augusto Gallino, Victor Aboyans, Curt Diehm, Francesco Cosentino, Hans Stricker, Erling Falk, Olaf Schouten, John Lekakis, Beatrice Amann-Vesti, Francesco Siclari, Pavel Poredos, Salvatore Novo, Marianne Brodmann, Karl-Ludwig Schulte, Charalambos Vlachopoulos, Raffaele De Caterina, Peter Libby, Iris Baumgartner
Abstract: During the last decades, the clinical and research interest in atherosclerosis has been mostly focused on coronary arteries. After the publications of the European Society Guidelines and AHA/ACC Guidelines on Peripheral artery diseases, and of the Registry REduction in Atherothrombosis for Continued Health Registry, there has been an increased interest in atherosclerosis of the lower extremity arteries and its presence in multifocal disease. However, awareness in the general population and the medical community of non-coronary artery diseases, and of its major prognostic implications remain relatively low. The aim of this general review stemming out of an ESC Working Group on Peripheral Circulation meeting in 2011 is to enhance awareness of this complex disease highlighting the importance of the involvement of atherosclerosis at different levels with respect to clinical presentation, diagnosis, and co-existence of the disease in the distinct arterial territories. We also emphasize the need of an interdisciplinary approach to face the broad and complex spectrum of multifocal disease, and try to propose a series of tentative recommendations and measures to be implemented in non-coronary atherosclerosis.
A position statement from the European Society of Cardiology Working Group on Peripheral Circulation
Published in the European Journal of Cardiovascular Prevention & Rehabilitation; 0(00) 1–15; Epub 2011 January 4thDOI: 10.1177/1741826711398179
Authors: J Lekakis, P Abraham, A Balbarini, A Blann, C M Boulanger, J Cockcroft, F Cosentino, J Deanfield, A Gallino, I Ikonomidis, D Kremastinos, U Landmesser, A Protogerou, C Stefanadis, D Tousoulis, G Vassalli, H Vink, N Werner, I Wilkinson and CVlachopoulos.
Summary: This paper presents in vivo and ex vivo methods for evaluating endothelial function with special focus on more recent ones. Insights and practical informations on the theoretical basis, methodological aspects and clinical application in various disease states are discussed. The ability of these methods to detect endothelial dysfunction before overt cardiovascular disease manifests make them attractive clinical tools for prevention.